0 items USD 0.00Search
Your search for "marketline ssbv rovsing strategy swot corporate finance report" gave back 7222 results.
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
TCR Engineered T-Cell Therapy 2018: an industry analysis of technologies, pipelines, stakeholders & deals T-Cell Receptors (TCR) and Chimeric...
Catalog:
La Merie Publishing
May 2018
Price: USD 2,500.00
Vectorized Antibodies for In Vivo Expression by DNA and mRNA report provides you with a landscape description and analysis of direct in vivo delivery...
Catalog:
La Merie Publishing
July 2021
Price: USD 2,550.00
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of...
Catalog:
La Merie Publishing
January 2018
Price: USD 2,800.00
Diarrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,000.00
Proteinase Activated Receptor 2 - Pipeline Review, H2 2019 Summary Proteinase Activated Receptor 2 (PAR2 or Coagulation Factor II Receptor Like 1 or...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Glucose Dependent Insulinotropic Receptor - Pipeline Review, H2 2020 Summary Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Glucose Dependent Insulinotropic Receptor - Pipeline Review, H1 2020 Summary According to the recently published report 'Glucose Dependent...
Catalog:
Global Markets Direct
March 2020
Price: USD 3,500.00
Bacillary Dysentery (Shigellosis) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
August 2018
Price: USD 2,000.00
Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
February 2018
Price: USD 2,000.00
Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) Drugs in Development by Therapy Areas and Indications, Stages,...
Catalog:
Global Markets Direct
July 2022
Price: USD 3,500.00
Glucose Dependent Insulinotropic Receptor - Drugs In Development, 2021 Summary Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Drugs In Development, 2021 Summary Muscarinic Acetylcholine Receptor M2 (CHRM2) pipeline Target...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Bacillary Dysentery - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
